Literature DB >> 27606095

Pulmonary hypertension: evolution of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Ryan J Anderson1, Atul Malhotra2, Nick H Kim2.   

Abstract

Entities:  

Year:  2016        PMID: 27606095      PMCID: PMC4990675          DOI: 10.21037/jtd.2016.07.33

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

1.  Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients.

Authors:  Michael M Madani; William R Auger; Victor Pretorius; Naohide Sakakibara; Kim M Kerr; Nick H Kim; Peter F Fedullo; Stuart W Jamieson
Journal:  Ann Thorac Surg       Date:  2012-05-23       Impact factor: 4.330

2.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

Review 3.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

Authors:  Anton Vonk-Noordegraaf; François Haddad; Kelly M Chin; Paul R Forfia; Steven M Kawut; Joost Lumens; Robert Naeije; John Newman; Ronald J Oudiz; Steve Provencher; Adam Torbicki; Norbert F Voelkel; Paul M Hassoun
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

Review 4.  Treatment goals of pulmonary hypertension.

Authors:  Vallerie V McLaughlin; Sean Patrick Gaine; Luke S Howard; Hanno H Leuchte; Michael A Mathier; Sanjay Mehta; Massimillano Palazzini; Myung H Park; Victor F Tapson; Olivier Sitbon
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

Review 5.  Updated clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Michael A Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R Krishna Kumar; Michael Landzberg; Roberto F Machado; Horst Olschewski; Ivan M Robbins; Rogiero Souza
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

6.  Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.

Authors:  L J Rubin; B M Groves; J T Reeves; M Frosolono; F Handel; A E Cato
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

7.  Proximal pulmonary arterial obstruction decreases the time constant of the pulmonary circulation and increases right ventricular afterload.

Authors:  Alberto Pagnamenta; Rebecca Vanderpool; Serge Brimioulle; Robert Naeije
Journal:  J Appl Physiol (1985)       Date:  2013-03-28

Review 8.  New horizons in pulmonary arterial hypertension therapies.

Authors:  Nazzareno Galiè; Ardeschir-Hossein Ghofrani
Journal:  Eur Respir Rev       Date:  2013-12

Review 9.  Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension.

Authors:  Daniel T Matthews; Anna R Hemnes
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

10.  Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study.

Authors:  Roderick C Deaño; Cherylanne Glassner-Kolmin; Melvyn Rubenfire; Adaani Frost; Scott Visovatti; Vallerie V McLaughlin; Mardi Gomberg-Maitland
Journal:  JAMA Intern Med       Date:  2013-05-27       Impact factor: 21.873

View more
  2 in total

1.  Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal.

Authors:  Max Schlueter; Amélie Beaudet; Evan Davies; Binu Gurung; Andreas Karabis
Journal:  BMC Pulm Med       Date:  2020-07-28       Impact factor: 3.317

2.  Disability and its clinical correlates in pulmonary hypertension measured through the World Health Organization Disability Assessment Schedule 2.0: a prospective, observational study.

Authors:  Abílio Reis; Mário Santos; Inês Furtado; Célia Cruz; Pedro Sa-Couto; Alexandra Queirós; Luís Almeida; Nelson Rocha
Journal:  J Bras Pneumol       Date:  2019-05-30       Impact factor: 2.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.